Mustang Bio, Inc. (MBIO)
0.37
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
Mustang Bio Market Cap : 2.804M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.804M |
| October 22, 2026 | 2.798M |
| October 21, 2026 | 2.901M |
| October 20, 2026 | 2.876M |
| October 19, 2026 | 2.826M |
| October 16, 2026 | 2.852M |
| October 15, 2026 | 2.926M |
| October 14, 2026 | 2.804M |
| October 13, 2026 | 2.855M |
| October 12, 2026 | 3.125M |
| October 09, 2026 | 3.032M |
| October 08, 2026 | 3.160M |
| October 07, 2026 | 3.411M |
| October 06, 2026 | 3.486M |
| October 05, 2026 | 3.486M |
| October 02, 2026 | 3.570M |
| October 01, 2026 | 3.540M |
| September 30, 2026 | 3.508M |
| September 29, 2026 | 3.634M |
| September 28, 2026 | 3.841M |
| September 25, 2026 | 3.943M |
| September 24, 2026 | 3.987M |
| September 23, 2026 | 3.875M |
| September 22, 2026 | 4.024M |
| September 21, 2026 | 4.168M |
| Date | Value |
|---|---|
| September 18, 2026 | 4.090M |
| September 17, 2026 | 3.713M |
| September 16, 2026 | 3.789M |
| September 15, 2026 | 3.815M |
| September 14, 2026 | 3.865M |
| September 11, 2026 | 3.843M |
| September 10, 2026 | 3.940M |
| September 09, 2026 | 4.002M |
| September 08, 2026 | 4.101M |
| September 04, 2026 | 4.114M |
| September 03, 2026 | 4.243M |
| September 02, 2026 | 4.115M |
| September 01, 2026 | 4.153M |
| August 31, 2026 | 4.073M |
| August 28, 2026 | 4.074M |
| August 27, 2026 | 4.168M |
| August 26, 2026 | 4.243M |
| August 25, 2026 | 4.183M |
| August 24, 2026 | 4.178M |
| August 21, 2026 | 4.385M |
| August 20, 2026 | 4.341M |
| August 19, 2026 | 4.350M |
| August 18, 2026 | 4.319M |
| August 17, 2026 | 4.503M |
| August 14, 2026 | 4.497M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Anika Therapeutics, Inc. | 286.66M |
| Savara, Inc. | 866.79M |
| Vericel Corp. | 2.176B |
Market Cap Related Metrics
| Price to Book Value | 0.3716 |
| Price | 0.37 |
| Earnings Yield | -121.6% |